Jane Street’s Pliant Therapeutics PLRX Stock Holding History

Jane Street’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.8K	Buy	+12,500	New	+$15.8K	﹤0.01%	11237
2025 Q1	–	Sell	-193,700	Closed	-$2.55M	–	10349
2024 Q4	$2.55M	Buy	193,700 +9,600	+5%	+$131K	﹤0.01%	3701
2024 Q3	$2.06M	Sell	184,100 -2,700	-1%	-$33.8K	﹤0.01%	4404
2024 Q2	$2.01M	Buy	186,800 +1,000	+0.5%	+$12.9K	﹤0.01%	4459
2024 Q1	$2.77M	Buy	185,800 +700	+0.4%	+$11.5K	﹤0.01%	3532
2023 Q4	$3.35M	Buy	+185,100	New	+$2.81M	﹤0.01%	3454

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Jane Street's PLRX Position: Q1 2026 in Review

Jane Street reduced its Pliant Therapeutics (PLRX) stake by 45% in Q1 2026, selling an estimated $375K and leaving 356,794 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #8307.

Jane Street first reported a position in PLRX in Q2 2020 and has held it in 15 quarters since. The position peaked at $5.92M in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

Jane Street held 356,794 shares of Pliant Therapeutics worth $450K as of Q1 2026.
Jane Street sold 296,980 Pliant Therapeutics shares in Q1 2026, an estimated $375K.
Pliant Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8307 holding.
Jane Street first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 15 quarters since.
Jane Street's Pliant Therapeutics position peaked at $5.92M in Q1 2023.
91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.